<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder characterized by premature cranial ossification resulting from fibroblast growth factor receptor-2 (FGFR-2)-activating mutations </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied the effects of the prominent S252W FGFR-2 Apert mutation on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and the underlying mechanisms in human mutant osteoblasts </plain></SENT>
<SENT sid="2" pm="."><plain>In vivo analysis of terminal deoxynucleotidyl transferase-mediated nick-end labeling revealed premature <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of mature osteoblasts and osteocytes in the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> suture compared to <z:mpath ids='MPATH_458'>normal</z:mpath> coronal suture </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro, mutant osteoblasts showed <z:mp ids='MP_0006042'>increased apoptosis</z:mp>, as demonstrated by terminal deoxynucleotidyl transferase-mediated nick-end labeling analysis, trypan blue staining, and DNA fragmentation </plain></SENT>
<SENT sid="4" pm="."><plain>Mutant osteoblasts also showed increased activity of caspase-8 and effector caspases (-3, -6, -7) constitutively </plain></SENT>
<SENT sid="5" pm="."><plain>This was related to protein kinase C activation because the selective <z:chebi fb="0" ids="37700">protein kinase C inhibitor</z:chebi> calphostin C inhibited caspase-8, effector caspases, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in mutant osteoblasts </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts also showed increased expression of interleukin (IL)-1alpha, IL-1beta, Fas, and Bax, and decreased Bcl-2 levels </plain></SENT>
<SENT sid="7" pm="."><plain>Specific neutralizing anti-IL-1 antibody reduced Fas levels, Bax expression, effector caspases activity, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in mutant cells </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> S252W FGFR-2 mutation promotes <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in human osteoblasts through activation of protein kinase C, overexpression of IL-1 and Fas, activation of caspase-8, and increased Bax/Bcl-2 levels, leading to increased effector caspases and DNA fragmentation </plain></SENT>
<SENT sid="9" pm="."><plain>This identifies a complex FGFR-2 signaling pathway involved in the premature <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> S252W FGFR-2 mutation in human calvaria osteoblasts </plain></SENT>
</text></document>